RMR Wealth Builders’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
RMR Wealth Builders's BMY Position: Q3 2026 in Review
RMR Wealth Builders reduced its Bristol-Myers Squibb (BMY) stake by 8.3% in Q3 2026, selling an estimated $59.2K and leaving 10,355 shares worth $646K. The position accounts for 0.04% of the portfolio, ranked #166.
RMR Wealth Builders first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $682K in Q3 2020. 2,547 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- RMR Wealth Builders held 10,355 shares of Bristol-Myers Squibb worth $646K as of Q3 2026.
- RMR Wealth Builders sold 936 Bristol-Myers Squibb shares in Q3 2026, an estimated $59.2K.
- Bristol-Myers Squibb made up 0.04% of RMR Wealth Builders's portfolio in Q3 2026, its #166 holding.
- RMR Wealth Builders first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
- RMR Wealth Builders's Bristol-Myers Squibb position peaked at $682K in Q3 2020.
- 2,547 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on RMR Wealth Builders's 13F filing for Q3 2026, filed 22 Oct 2026.